Previous Article | Next Article 
Clinical and Diagnostic Laboratory Immunology, September 2000, p. 774-777, Vol. 7, No. 5
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Serotype-Cross-Reactive Immunoglobulin M Responses in Dengue
Virus Infections Determined by Enzyme-Linked Immunosorbent
Assay
Masaru
Nawa,1,*
Ken-Ichiro
Yamada,2
Tomohiko
Takasaki,2
Toshitaka
Akatsuka,1 and
Ichiro
Kurane2
Department of Microbiology, Saitama Medical
School, Saitama 350-0495,1 and
Department of Virology 1, National Institute of Infectious
Diseases, Shinjyuku, Tokyo 162-8640,2 Japan
Received 1 February 2000/Returned for modification 4 April
2000/Accepted 31 May 2000
 |
ABSTRACT |
We developed immunoglobulin M (IgM) antibody capture enzyme-linked
immunosorbent assays (ELISAs) with four monovalent dengue virus
antigens. We attempted to determine whether IgM responses in dengue
virus infections are serotype specific or serotype cross-reactive. Serum samples from 14 confirmed dengue cases were examined. In these 14 cases, which consisted of 12 Japanese and 2 non-Japanese patients,
infecting dengue virus serotypes were defined by reverse transcription-PCR. Thirteen of the 14 cases were IgM positive in ELISA.
IgM responses were serotype cross-reactive in these 13 cases but were
highest against infecting dengue virus serotype in 9 of the 13 cases.
These results indicate that IgM responses are generally dengue serotype
cross-reactive but that IgM levels are highest against the infecting
serotype in most dengue cases.
 |
INTRODUCTION |
Dengue is currently one of the most
important arboviral diseases of humans. Dengue viruses, members of the
family Flaviviridae, include four antigenically
cross-reactive serotypes and are endemic in the tropical and
subtropical countries of the world. The lack of effective mosquito
control measures in areas where dengue is endemic maintains a high
incidence of dengue. An increase in the number of people travelling by
air results in a spread of dengue to most tropical and subtropical
areas of the world.
Monitoring of dengue virus infections is an important component of
assessing the disease risk to humans. Laboratory tests are necessary
for confirmation of the diagnosis of dengue (8). Detection
of the viral nucleic acids is an alternative to virus isolation and/or
antigen detection. Reverse transcription-PCR (RT-PCR) is a sensitive
technique for detection of dengue viral RNA in serum samples
(7); however, dengue viral RNA is not usually detected in
sera after defervescence (9). Enzyme-linked immunosorbent
assay (ELISA) is a sensitive, specific, and rapid technique to detect
virus-specific antibodies. In addition, ELISA requires less specialized
equipment than PCR, making it a practical technique for use in laboratories.
Although detection of dengue immunoglobulin M (IgM) is widely used
diagnostic method for dengue, it has not been determined whether IgM
responses in dengue virus infections are dengue virus serotype specific
or serotype cross-reactive. In this paper, we report the development of
an IgM capture ELISA with monovalent dengue virus antigens. We applied
the IgM capture ELISA to serum samples from confirmed dengue cases. We
find that IgM responses are dengue virus serotype cross-reactive in
most cases but that the highest responses are against the infecting serotype.
 |
MATERIALS AND METHODS |
Serum specimens.
Thirty-four acute- and convalescent-phase
serum samples were obtained for laboratory diagnosis from 12 Japanese
and 2 non-Japanese patients. The patients were infected with dengue
viruses in areas where dengue is epidemic and became ill in Japan.
Twenty-seven serum samples were also obtained from 17 suspected
Japanese dengue cases.
Serum samples were collected from 33 healthy Japanese subjects who had
never been to areas where dengue is epidemic, and these were used as
anti-dengue virus IgM negative controls in the study. All 94 serum
samples were first tested for the presence of anti-dengue virus IgM
antibody by use of the commercially available Dengue Fever IgM Capture
ELISA kit (MRL Diagnostics).
Anti-flavivirus IgG and preparation of the conjugate.
Pooled
sera from Filipino dengue patients were collected, and IgG was purified
by protein G affinity column chromatography (ImmunoPureG IgG
purification kit; Pierce) according to the manufacturer's instruction.
Purified IgG was conjugated with horseradish peroxidase (EZ-Link Plus
Activated Peroxidase kit; Pierce) according to the manufacturer's
instruction and used at a 1:500 dilution (1 µg of protein per ml).
ELISA antigens.
Four prototype dengue strains (type 1, Hawaii; type 2, New Guinea C; type 3, H87; and type 4, H241) were used
as the antigens. Viruses were grown in the Aedes albopictus
mosquito cell clone C6/36 (4). C6/36 cells were cultured in
Dulbecco modified Eagle's medium supplemented with 10% fetal calf
serum at 28°C. The cells were infected with dengue viruses at a
multiplicity of infection higher than 1 PFU per cell and maintained at
28 or 32°C in 2% fetal calf serum-Dulbecco modified Eagle's medium
for 5 to 6 days. Culture supernatant fluids were harvested and
centrifuged at 10,000 × g for 30 min at 4°C to
remove cell debris, and the resultant supernatants were used as the
viral antigen in the assays. Control antigen was similarly prepared
from uninfected C6/36 cells.
Antigen titration was carried out by an antibody sandwich ELISA using
the human anti-flavivirus IgG and its peroxidase conjugate, in order to
prepare the tetravalent and four monovalent dengue virus antigens (Fig.
1). Briefly, wells of the ELISA plate
(Nunc) were coated with 0.1 ml of human anti-flavivirus IgG at a 1:500 dilution (1 µg of protein per ml) in 0.05 M carbonate buffer, pH 9.6. After 2.5 h of incubation at room temperature, the wells were
washed with phosphate-buffered saline (PBS) (pH 7.4) containing 0.05%
Tween 20 (PBS-Tween) and then reacted with serial dilutions of viral
antigens in 0.1 ml per well for 1 h at room temperature. Captured
antigens were detected by incubation for 1 h with 0.1 ml of the
conjugated human anti-flavivirus IgG at a dilution of 1:500, and
A492 readings were recorded. Based on antigen
titration curves, each of the monovalent dengue virus antigens was
adjusted to an A492 of 1.0. The tetravalent
antigen was prepared by mixing equal volumes of each monovalent antigen
at a 4-times-higher concentration.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Titration of dengue viral antigens by a sandwich ELISA.
Prototype dengue virus type 1 ( )-, type 2 ( )-, type 3 ( )-, and
type 4 ( )-infected C6/36 cell culture fluids were diluted with
uninfected control culture fluid as the diluent.
|
|
Development of ELISA with monovalent and tetravalent
antigens.
The tetravalent dengue virus antigen was used at
dilutions of 1:1, 1:2, and 1:4 (Fig. 2).
Serum samples obtained from 33 healthy Japanese adults were used as
negative controls. Thirteen sera from 11 dengue patients and 4 reference sera which were provided with the commercial kit, two
IgM-positive sera, one cutoff calibrator, and one IgM-negative serum
were also tested in the assays.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 2.
Index values obtained in ELISA using tetravalent dengue
virus antigen at various dilutions. The tetravalent dengue virus
antigen (Ag.) was used at dilutions of 1:1, 1:2, and 1:4. Sera from 33 healthy Japanese adults ( ) and 11 IgM-positive dengue patients ( )
and four reference sera given in the commercial kit ( ) were used in
the assay. H, L, C, and N, high IgM-positive, low IgM-positive, cutoff
calibrator, and IgM-negative sera for the commercial ELISA kit,
respectively.
|
|
The average (
n
1) and standard
deviation (SD) (S2) using negative control sera
were calculated for each antigen dilution. Average index values ± SDs of these negative control sera with antigen at 1:1, 1:2, and 1:4
dilutions were 2.14 ± 0.257, 1.61 ± 0.137, and 1.35 ± 0.087, respectively. Average index values + 3 SDs were 2.911, 2.021, and 1.611 for antigen dilutions of 1:1, 1:2, and 1:4,
respectively. Based on these results, the tetravalent antigen was used
at 1:4 dilution with the cutoff value of 2.0 in the ELISA.
ELISA.
IgM ELISA was performed according to the method
reported by Bundo and Igarashi with modifications (1). Wells
of the immunoplate were sensitized with 0.1 ml of the goat anti-human
IgM (µ chain specific) antibody (Zymed) at a dilution of 1:500 (2 µg of protein per ml) in 0.05 M carbonate buffer, pH 9.6. After
2.5 h of incubation at room temperature, the wells were washed
three times with PBS-Tween. One hundred microliters of the serum
samples diluted at 1:101 in PBS plus 10% anti-Japanese encephalitis
virus antibody-free calf serum (Wako Pure Chemical) was added to six
wells and incubated for 1 h at room temperature. After washing
with PBS-Tween, 0.1-ml portions of tetravalent antigen, each of the
four monovalent antigens, and uninfected control antigens were added to
each well and incubated for 1 h at room temperature. The plates
were washed, and 1:500-diluted peroxidase-conjugated human
anti-flavivirus IgG was added and incubated for 1 h at room
temperature. After washing, an enzyme substrate,
o-phenylenediamine 2HCl and H2O2 in
0.1 M citrate buffer (pH 5.0), was added and incubated for 30 min at
room temperature. The stop reagent, 2.5 M
H2SO4, was then added, and the resultant color
change was quantified by A492 readings.
The index value was calculated by the formula
A492 with the viral
antigen/A492 with uninfected control antigen. We
defined an index value of 2.0 or greater as positive. We always
included negative and positive standard samples in each
assay. The commercial ELISA kit (Dengue Fever IgM Capture ELISA
kit) was purchased from MRL Diagnostics. The tests
were carried out according to the manufacturer's instruction,
and an index value of 1.0 or greater was considered positive.
RT-PCR.
Extraction of RNA was performed as previously
reported (8). Fifty microliters of serum sample was mixed
with 0.2 ml of Isogen-LS (Nippon Gene, Tokyo, Japan) for 10 s, and
0.04 ml of chloroform was added. The mixture was centrifuged for 10 min
at 12,000 × g. One hundred fifty microliters of the
aqueous phase was mixed with an equal volume of isopropanol for 10 s, and the mixture was kept at room temperature for 5 min. The mixture
was centrifuged at 12,000 × g for 10 min. The RNA was
washed once with 75% ethanol and resuspended in 0.05 ml of RNase-free water.
RT-PCR was performed according to the method reported by Morita et al.,
with a minor modification (7). RT and PCR were done
sequentially in a single tube. The tubes were set in a oil bath type
thermal cycler (Iwaki Co., Tokyo, Japan) and subjected to programmed
incubation at 53°C for 10 min for reverse transcription, followed by
30 to 40 PCR cycles of amplification. PCR products were then subjected
to agarose gel electrophoresis. Amplified DNA fragments were visualized
by ethidium bromide staining. The primer sequences used to detect each
serotype of dengue virus and the target sizes are listed in Table
1.
 |
RESULTS |
Comparison of the in-house ELISA with the commercial ELISA
kit.
We attempted to determine dengue virus serotype specificity
or cross-reactivity of IgM responses in dengue virus infections. Because ELISA using monovalent dengue virus antigen was not
commercially available, we first developed ELISA with monovalent
and tetravalent dengue virus antigens. The development of in-house
dengue virus ELISA is described in Materials and Methods. We then
compared the in-house ELISA with the commercial ELISA kit. Fifty-seven serum samples from confirmed and suspected dengue cases were tested by
the in-house and the commercial ELISAs, and the results were compared
(Table 2). When all of the results of the
in-house ELISA with tetravalent and monovalent antigens are
included, the results are consistent between our in-house ELISA and the
commercial one, except for one sample (data not shown).
Serodiagnosis of dengue by ELISA using monovalent dengue virus
antigen.
We examined the serotype specificity or cross-reactivity
of IgM antibody responses, using the in-house ELISA with the
tetravalent dengue virus antigen and the antigens of each of four
dengue virus serotypes. Thirty-four serum samples from 14 dengue
patients were tested. Infecting dengue virus serotypes were determined
by PCR for these 14 patients (cases 1 to 14) (Table
3).
Cases 1 to 14 included 12 Japanese cases and 2 non-Japanese cases
(cases 13 and 14). Index values were greater than 2.0 by ELISA using
tetravalent or monovalent antigens in 13 of the 14 cases. The day 8 serum sample from case 11, which was IgM negative in ELISA with
tetravalent antigen, was positive in ELISA with dengue virus type 2 and
type 4 antigens. Serum samples obtained from case 12 were determined to
be IgM negative in the ELISA. These serum samples were obtained on days
early in disease, and it is likely that IgM was not produced to a
detectable level.
Index values were equal to or greater than 2 for all four dengue virus
serotypes in 12 of the 13 IgM-positive cases. IgM levels when using the
monovalent ELISA, however, were highest against the infecting dengue
virus serotype in 9 of the 13 cases. These results suggest that IgM
responses are dengue virus serotype cross-reactive but are highest
against the infecting serotype in most cases.
 |
DISCUSSION |
We developed an IgM ELISA using tetravalent dengue virus antigen
or antigens of each of four dengue virus serotypes. The sensitivity and
specificity of our in-house ELISA were confirmed by comparison with a
commercial one (Table 2). The ELISA was then applied to serum
samples from 14 PCR-confirmed dengue cases (Table 3). The sensitivity
of IgM ELISA in detecting dengue virus infection was again
supported by the results that IgM responses were detected in 13 out of
14 confirmed cases. It is likely that serum samples from case 12 were
negative for anti-dengue virus IgM because they were obtained on early
days of the illness. We examined the serotype specificity and
cross-reactivity of IgM antibody responses. In 9 of 12 cases, namely, 9 of 10 Japanese cases, IgM levels were higher against the infecting
dengue virus serotype than against three other serotypes (Table 3),
although IgM responses against the three other serotypes were also
positive. The serotypes to which the highest IgM antibody responses
were directed were consistent with the PCR-determined infecting dengue
virus serotypes.
Since IgM ELISA was introduced for serodiagnosis of dengue
(3), most of the ELISAs have utilized dengue virus antigens prepared from infected mouse brains or infected C6/36 cell culture fluids. We used culture fluids of dengue virus-infected C6/36 cells as
assay antigens. It is important to develop culture systems which supply
high titers of dengue viruses in the culture supernatants. Mohamed et
al. (6) reported that the amount of dengue virus type 2 and
type 3 viral antigens produced in C6/36 cell culture fluid increased
when the incubation temperature was elevated from 28 to 32 or 37°C.
Our study showed that dengue virus type 1, Hawaii strain, was produced
to a higher titer at 32 or 37°C (data not shown). Similar attempts to
produce higher titers of dengue virus types 2, 3, and 4 at 32 or 37°C
were not successful.
The established IgM ELISA was useful for diagnosis of dengue. We
already reported that RT-PCR was useful for diagnosis of dengue when
serum samples were collected from patients with fever (9).
On the other hand, the IgM ELISA tends to be positive after
defervescence (9). Thus, application of both of IgM ELISA and RT-PCR increases the ability to diagnose dengue virus infections. In the present study, we examined serotype specificity and
cross-reactivity of IgM responses, using serum samples from
PCR-confirmed dengue cases. The serotype specificity of IgM responses
in dengue patients has been variously stated (2, 3, 5).
Burke reported that serotype-specific IgM responses corresponding to
the isolated virus type were detected in all 16 patients with primary
dengue virus infection tested (2, 5). Gubler reported that
in dengue infection, monotypic IgM responses frequently are not
correlated with the virus serotype isolated from a patients
(3). We found that IgM responses were generally serotype
cross-reactive but that IgM levels were highest against the infecting
dengue virus serotype in most cases. Although more patient samples need
to be tested to confirm our observation, the results provide
interesting insights into human antibody responses to dengue viruses.
 |
ACKNOWLEDGMENTS |
We thank the doctors of 24 clinics and hospitals for providing us
serum samples for diagnosis of dengue.
This work was supported by grants from the Research on Emerging and
Re-emerging Infectious Diseases program, Ministry of Health and Welfare
of Japan; from the Program for Promotion of Fundamental Studies in
Health Sciences of the Organization for Drug ADR Relief, R & D
Promotion and Product Review of Japan; and by Cooperative Research
Grant 1999 (11-a-2) of the Department of Tropical Medicine, Nagasaki
University. M. Nawa was supported by World Health Organization grant
CDS/JPN/97/01.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology, Saitama Medical School, 38 Moroyama, Saitama 350-0495, Japan. Phone: 81 492 76 1166. Fax: 81 492 95 9107. E-mail:
mnawa{at}saitama-med.ac.jp.
 |
REFERENCES |
| 1.
|
Bundo, K., and A. Igarashi.
1985.
Antibody-capture ELISA for detection of immunoglobulin M antibodies in sera from Japanese encephalitis and dengue hemorrhagic fever patients.
J. Virol. Methods
11:15-22[CrossRef][Medline].
|
| 2.
|
Burke, D. S.
1983.
Rapid methods in the laboratory diagnosis of dengue virus infections, p. 72-84.
In
T. Pang, and R. Pathmananathan (ed.), Proceedings of the International Conference Dengue/Dengue Hemorrhagic Fever. University of Malaya, Kuala Lumpur, Malasia.
|
| 3.
|
Gubler, D. J.
1998.
Dengue and dengue hemorrhagic fever.
Clin. Microbiol. Rev.
11:480-496[Abstract/Free Full Text].
|
| 4.
|
Igarashi, A.
1978.
Isolation of a Singh's Aedes albopictus cell clone sensitive to dengue and chikungunya viruses.
J. Gen. Virol.
40:531-544[Abstract/Free Full Text].
|
| 5.
|
Innis, B. L.
1997.
Antibody responses to dengue virus infection, p. 221-243.
In
D. J. Gubler, and G. Kuno (ed.), Dengue and dengue hemorrhagic fever. CBA International, Wallingford, United Kingdom.
|
| 6.
|
Mohamed, H.,
L. D. Castillo,
M. Sinniah, and A. Igarashi.
1995.
Elevated incubation temperature enhanced antigen production of dengue type 2 and 3 viruses in the infected Aedes albopictus clone C6/36 cell culture.
Trop. Med.
37:21-27.
|
| 7.
|
Morita, K.,
M. Tanaka, and A. Igarashi.
1991.
Rapid identification of dengue virus serotypes by using polymerase chain reaction.
J. Clin. Microbiol.
29:2107-2110[Abstract/Free Full Text].
|
| 8.
|
Yamada, K.,
T. Takasaki,
M. Nawa, and I. Kurane.
1999.
Laboratory diagnosis of imported dengue cases.
Jpn. J. Trop. Med. Hyg.
27:75-77.
|
| 9.
|
Yamada, K.,
M. Nawa,
T. Takasaki,
S. Yabe, and I. Kurane.
1999.
Laboratory diagnosis of dengue virus infections by reverse transcriptase polymerase chain reaction (RT-PCR) and IgM-capture enzyme-linked immunosorbent assay (ELISA).
Jpn. J. Infect. Dis.
52:150-155[Medline].
|
Clinical and Diagnostic Laboratory Immunology, September 2000, p. 774-777, Vol. 7, No. 5
1071-412X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
AnandaRao, R., Swaminathan, S., Fernando, S., Jana, A. M., Khanna, N.
(2006). Recombinant Multiepitope Protein for Early Detection of Dengue Infections. CVI
13: 59-67
[Abstract]
[Full Text]
-
Nawa, M., Takasaki, T., Ito, M., Inoue, S., Morita, K., Kurane, I.
(2005). Immunoglobulin A Antibody Responses in Dengue Patients: a Useful Marker for Serodiagnosis of Dengue Virus Infection. CVI
12: 1235-1237
[Abstract]
[Full Text]
-
Holmes, D. A., Purdy, D. E., Chao, D.-Y., Noga, A. J., Chang, G.-J. J.
(2005). Comparative Analysis of Immunoglobulin M (IgM) Capture Enzyme-Linked Immunosorbent Assay Using Virus-Like Particles or Virus-Infected Mouse Brain Antigens To Detect IgM Antibody in Sera from Patients with Evident Flaviviral Infections. J. Clin. Microbiol.
43: 3227-3236
[Abstract]
[Full Text]
-
Taylor, C., Simmons, R., Smith, I.
(2005). Development of Immunoglobulin M Capture Enzyme-Linked Immunosorbent Assay To Differentiate Human Flavivirus Infections Occurring in Australia. CVI
12: 371-374
[Abstract]
[Full Text]
-
Ito, M., Takasaki, T., Yamada, K.-I., Nerome, R., Tajima, S., Kurane, I.
(2004). Development and Evaluation of Fluorogenic TaqMan Reverse Transcriptase PCR Assays for Detection of Dengue Virus Types 1 to 4. J. Clin. Microbiol.
42: 5935-5937
[Abstract]
[Full Text]
-
Shu, P.-Y., Huang, J.-H.
(2004). Current Advances in Dengue Diagnosis. CVI
11: 642-650
[Full Text]
-
Shu, P.-Y., Chen, L.-K., Chang, S.-F., Su, C.-L., Chien, L.-J., Chin, C., Lin, T.-H., Huang, J.-H.
(2004). Dengue Virus Serotyping Based on Envelope and Membrane and Nonstructural Protein NS1 Serotype-Specific Capture Immunoglobulin M Enzyme-Linked Immunosorbent Assays. J. Clin. Microbiol.
42: 2489-2494
[Abstract]
[Full Text]
-
Mishra, B., Ratho, R. K., Kabilan, L.
(2004). Virological Interpretations of Dengue Disease Spectrum in Infants in Chennai, Tamil Nadu, India, Need Reevaluation. J. Clin. Microbiol.
42: 2357-2358
[Full Text]
-
Yamada, K.-I., Takasaki, T., Nawa, M., Yabe, S., Kurane, I.
(2003). Antibody Responses Determined for Japanese Dengue Fever Patients by Neutralization and Hemagglutination Inhibition Assays Demonstrate Cross-Reactivity between Dengue and Japanese Encephalitis Viruses. CVI
10: 725-728
[Abstract]
[Full Text]
-
Ludolfs, D., Schilling, S., Altenschmidt, J., Schmitz, H.
(2002). Serological Differentiation of Infections with Dengue Virus Serotypes 1 to 4 by Using Recombinant Antigens. J. Clin. Microbiol.
40: 4317-4320
[Abstract]
[Full Text]